The selection of children and adolescents for treatment with continuous subcutaneous insulin infusion (CSII)

Corresponding Author

Lynda K. Fisher

The Center for Endocrinology, Diabetes, and Metabolism, The Keck School of Medicine of the University of Southern California, 4650 Sunset Blvd, MS #61, Los Angeles, CA 90027, USA

*Lynda K. Fisher, MD
The Center for Endocrinology,
Diabetes, and Metabolism
The Keck School of Medicine of
the University of Southern California
4650 Sunset Blvd
MS #61
Los Angeles
CA 90027
USA
e-mail: [email protected]Search for more papers by this author

Lynda K. Fisher,

Corresponding Author

Lynda K. Fisher

The Center for Endocrinology, Diabetes, and Metabolism, The Keck School of Medicine of the University of Southern California, 4650 Sunset Blvd, MS #61, Los Angeles, CA 90027, USA

First published: 09 June 2006

https://doi.org/10.1111/j.1399-543X.2006.00173.x

Citations: 9

Share a link

Email
Wechat
Bluesky

Abstract

Abstract: Continuous subcutaneous insulin infusion (CSII) was first introduced as a mode of treatment for persons with type 1 diabetes mellitus (T1DM) in the late 1970s. Since that time, there have been many reports and reviews of this modality of treatment in adults and adolescents with diabetes and several reports of the use of this technology in the treatment of children with T1DM. Conflicting data have accumulated on the consistency of improvement in hemoglobin A1c (HbA1c) and in the frequency of complications, most significantly that of hypoglycemia. Some studies report the findings of controlled randomized studies, but many of these studies were conducted on small numbers of highly selected patients. Some studies are prospective but not randomized, where subjects pre-CSII serve as their own controls. Yet other studies are retrospective reviews of children and adolescents who have been treated with CSII. This paper reviews what has been learned about patient selection and outcomes of CSII treatment, with the goal of outlining steps in the selection and preparation of patients for CSII that will facilitate optimum outcome.

References

1 Pickup JC, Keen H, Parsons JA, Alberti KGMM. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J 1978: 7: 204–207.
10.1136/bmj.1.6107.204
Web of Science® Google Scholar
2 Pickup JC, White MC, Keen H, Parsons JA, Alberti KG. Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet 1979: 2: 870–873.
10.1016/S0140-6736(79)92686-2
CAS PubMed Web of Science® Google Scholar
3 Tamborlane WV, Sherwin RS, Genel M, Felic P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979: 300: 573–578.
10.1056/NEJM197903153001101
CAS PubMed Web of Science® Google Scholar
4 Tamborlane WV, Sherwin RS, Genel M, Felig P. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. Am J Med 1980: 68: 190–196.
10.1016/0002-9343(80)90353-8
CAS PubMed Web of Science® Google Scholar
5 Schiffrin AD, Belmonte MM. Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin: a one-year prospective study. Diabetes 1982: 331: 255–264.
Web of Science® Google Scholar
6 Bougneres PF, Landier MD, Lemmel C, Mensire A, Chaussain JL. Insulin pump therapy in young children with type 1 diabetes. J Pediatr 1984: 105: 212–217.
10.1016/S0022-3476(84)80115-8
PubMed Web of Science® Google Scholar
7 Chantelau E, Spraul M, Muhihauser I, Gause R, Berger M. Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologia 1989: 32: 421–426.
10.1007/BF00271261
CAS PubMed Web of Science® Google Scholar
8 Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977–985.
10.1002/(SICI)1097-4695(199912)41:4<540::AID-NEU9>3.0.CO;2-P
PubMed Web of Science® Google Scholar
9 Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared to intensive insulin injection therapy in type I diabetes: meta-analysis of randomized controlled trials. BMJ 2002: 324: 705–711.
10.1136/bmj.324.7339.705
CAS PubMed Web of Science® Google Scholar
10 Weissberg-Benchell J, Antisdel-Lomaglio J. Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003: 26: 1079–1087.
10.2337/diacare.26.4.1079
PubMed Web of Science® Google Scholar
11 Willi SM, Planton J, Egede L, Schwarz S. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 2003: 143: 796–801.
10.1067/S0022-3476(03)00579-1
CAS PubMed Web of Science® Google Scholar
12 Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003: 26: 1142–1146.
10.2337/diacare.26.4.1142
PubMed Web of Science® Google Scholar
13 Weinzimer SA, Ahern JH, Doyle EA et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004: 114 (6): 1601–1605.
10.1542/peds.2004-0092
PubMed Web of Science® Google Scholar
14 Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr 2002: 141: 490–495.
10.1067/mpd.2002.127500
PubMed Web of Science® Google Scholar
15 Dimeglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA. A randomized controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004: 145: 380–384.
10.1016/j.jpeds.2004.06.022
CAS PubMed Web of Science® Google Scholar
16 Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005: 28: 1277–1281.
10.2337/diacare.28.6.1277
CAS PubMed Web of Science® Google Scholar
17 Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005: 28 (1): 15–19.
10.2337/diacare.28.1.15
PubMed Web of Science® Google Scholar
18 Weintrob N, Benzaquen H, Galatzer A et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003: 112: 559–564.
10.1542/peds.112.3.559
PubMed Web of Science® Google Scholar
19 Doyle (Boland) EA, Weinzimer SA, Steffen AT, Ahern JAH, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004: 27: 1554–1558.
10.2337/diacare.27.7.1554
PubMed Web of Science® Google Scholar
20 Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001: 107: 351–356.
10.1542/peds.107.2.351
CAS PubMed Web of Science® Google Scholar
21 Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane W. Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999: 22: 1779–1784.
10.2337/diacare.22.11.1779
CAS PubMed Web of Science® Google Scholar
22 Shehadeh N, Battelino T, Galatzer A et al. Insulin pump therapy for 1–6 year old children with type 1 diabetes. Isr Med Assoc J 2004: 6: 284–286.
CAS PubMed Web of Science® Google Scholar
23 Kaufman FR, Halvorson M, Fisher L, Pitukcheewanont P. Insulin pump therapy in type 1 pediatric patients. J Pediatr Endocrinol Metab 1999: 12 (Suppl. 3): 759–764.
PubMed Web of Science® Google Scholar
24 Steindel BS, Roe TR, Costin G, Carlson M, Kaufman FR. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 1995: 27: 199–204.
10.1016/0168-8227(95)01044-E
CAS PubMed Web of Science® Google Scholar
25 Burdick J, Chase P, Slover RH et al. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics 2004: 116: 221–224.
10.1542/peds.113.3.e221
Web of Science® Google Scholar
26 Silverstein J, Klingensmith G, Copeland K et al. Care of children and adolescents with type 1 diabetes. a statement of the American Diabetes Association. Diabetes Care 2005: 28: 186–212.
10.2337/diacare.28.1.186
PubMed Web of Science® Google Scholar

Citing Literature

All articles

The selection of children and adolescents for treatment with continuous subcutaneous insulin infusion (CSII)

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

The selection of children and adolescents for treatment with continuous subcutaneous insulin infusion (CSII)

Abstract

References

Citing Literature

References

Related

Information